Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Refresh Contacts
- Development stage
- Unknown
- Lead developer
- Allergan
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Refresh Contacts is an over-the-counter (OTC) lubricant eye drop formulation developed by Allergan (now part of AbbVie) specifically for contact lens wearers. The active ingredient is carboxymethylcellulose sodium (CMC), a viscosity-enhancing polymer that acts as an artificial tear to provide relief from dryness, irritation, and discomfort associated with wearing contact lenses. It is designed to be applied directly to the eye while lenses are in place, helping to rewet the lenses and stabilize the tear film. The formulation often includes the Purite preservative system, which breaks down into natural tear components upon exposure to light, minimizing potential ocular surface irritation.
- Brand names
- Refresh Contacts
- Other names
- carboxymethylcellulose sodium ophthalmic solution
Beyond the preview
Go deeper on Refresh Contacts.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Refresh Contacts.